The mitochondrial genome in aging and senescence

A Lauri, G Pompilio, MC Capogrossi - Ageing research reviews, 2014 - Elsevier
Aging is characterized by a progressive decline in organism functions due to the impairment
of all organs. The deterioration of both proliferative tissues in liver, skin and the vascular …

Herb-target virtual screening and network pharmacology for prediction of molecular mechanism of Danggui Beimu Kushen Wan for prostate cancer

H Li, A Hung, AWH Yang - Scientific Reports, 2021 - nature.com
Prostate cancer (PCa) is a cancer that occurs in the prostate with high morbidity and
mortality. Danggui Beimu Kushen Wan (DBKW) is a classic formula for patients with difficult …

Progression after First-Line Cyclin-Dependent Kinase 4/6 Inhibitor Treatment: Analysis of Molecular Mechanisms and Clinical Data

F Villa, A Crippa, D Pelizzoni, A Ardizzoia… - International Journal of …, 2023 - mdpi.com
Cyclin-dependent kinase 4/6 inhibitors (CDK4/6iss) are widely used in first-line metastatic
breast cancer. For patients with progression under CDK4/6is, there is currently no standard …

The Δ40p53 isoform inhibits p53-dependent eRNA transcription and enables regulation by signal-specific transcription factors during p53 activation

CB Levandowski, T Jones, M Gruca… - PLoS …, 2021 - journals.plos.org
The naturally occurring Δ40p53 isoform heterotetramerizes with wild-type p53 (WTp53) to
regulate development, aging, and stress responses. How Δ40p53 alters WTp53 function …

A new insight into cell biological and biochemical changes through aging

S Sahabi, D Jafari-Gharabaghlou, N Zarghami - Acta Histochemica, 2022 - Elsevier
After several years of extensive research, the main cause of aging is yet elusive. There are
some theories about aging, such as stem cell aging, senescent cells accumulation, and …

Rapalogs in cancer prevention: anti-aging or anticancer?

MV Blagosklonny - Cancer biology & therapy, 2012 - Taylor & Francis
Common cancer is an age-related disease. Slow aging is associated with reduced and
delayed carcinogenesis. Calorie restriction (CR), the most studied anti-aging intervention …

MYCN sensitizes neuroblastoma to the MDM2-p53 antagonists Nutlin-3 and MI-63

LD Gamble, UR Kees, DA Tweddle, J Lunec - Oncogene, 2012 - nature.com
MYCN amplification is a major biomarker of poor prognosis, occurring in 25–30% of
neuroblastomas. MYCN has contradictory roles in promoting cell growth and sensitizing …

[HTML][HTML] Dual mTORC1/C2 inhibitors suppress cellular geroconversion (a senescence program)

OV Leontieva, ZN Demidenko, MV Blagosklonny - Oncotarget, 2015 - ncbi.nlm.nih.gov
In proliferating cells, mTOR is active and promotes cell growth. When the cell cycle is
arrested, then mTOR converts reversible arrest to senescence (geroconversion). Rapamycin …

Suppression of replicative senescence by rapamycin in rodent embryonic cells

TV Pospelova, OV Leontieva, TV Bykova, SG Zubova… - Cell cycle, 2012 - Taylor & Francis
The TOR (target of rapamycin) pathway is involved in aging in diverse organisms from yeast
to mammals. We have previously demonstrated in human and rodent cells that mTOR …

MEK drives cyclin D1 hyperelevation during geroconversion

OV Leontieva, ZN Demidenko… - Cell Death & …, 2013 - nature.com
When the cell cycle becomes arrested, MTOR (mechanistic Target of Rapamycin) converts
reversible arrest into senescence (geroconversion). Hyperexpression of cyclin D1 is a …